Outcomes of Single-Level and Multi-Level Thoracoscopic Sympathectomy in Primary Axillary Hyperhidrosis: A Multicenter Retrospective Analysis
The European Research Journal · 2026-11-01 · 1233-1240
DOI: 10.18621/eurj.1206 ↗Abstract
Objective: To compare surgical outcomes across 3 sympathectomy levels in patients with primary axillary hyperhidrosis. Methods: This retrospective, multicenter study included 83 patients who underwent bilateral clip-based thoracoscopic sympathectomy for primary axillary hyperhidrosis between May 2009 and July 2023. Patients were stratified into 3 groups: single-level R3 (n = 24), single-level R4 (n = 35), and multilevel R2-R4 (n = 24). The primary outcome was the incidence of compensatory hyperhidrosis. Secondary outcomes included complete remission, recurrence, postoperative complications, and patient satisfaction. Factors associated with outcomes were evaluated using univariate and multivariate logistic regression analyses. Results: Compensatory hyperhidrosis occurred in 83.3% of patients in the R2-R4 group, compared with 75.0% in the R3 group and 54.3% in the R4 group (P = .05). Complete remission rates were comparable among groups (54.2%, 41.7%, and 34.3%, respectively; P = .45). In multivariate analysis, R4 sympathectomy was associated with significantly lower odds of CH compared with R2-R4 (OR, 0.25; 95% CI, 0.06-0.97; P = .04). Recurrence rates did not differ significantly among groups (20.8%, 25.7%, and 12.5%, respectively; P = .47). Recurrence was identified as the sole independent predictor of patient dissatisfaction (OR, 0.12; 95% CI, 0.03-0.44; P = .001). Conclusions: Single-level R4 sympathectomy appears to provide a favorable balance between treatment efficacy and side-effect profile in primary axillary hyperhidrosis. Multilevel approaches were not associated with improved clinical outcomes but were linked to higher rates of compensatory hyperhidrosis. These findings should be interpreted with caution.
EUVIMED